Gennev makes a specific kind of appointment available: a scheduled video consultation with a menopause-trained physician. For a person bringing several concerns, the challenge is deciding what the encounter needs to clarify first. Sleep, vaginal discomfort, an existing prescription and a question about hormones can compete for attention even when they belong to the same story.
Gennev’s service and pricing records were reviewed on September 28, 2026. We did not book a visit, verify a personal insurance policy or receive a treatment plan. The review considers how the advertised appointment, payment process and follow-on care could shape preparation, while leaving medical decisions to the treating professionals.
A timed conversation starts before the camera opens
The Gennev service page describes a short health-history questionnaire followed by selection of an appointment and payment method. It advertises thirty-minute physician video visits, with appointments available within a week. The availability statement is not a reserved slot, and this review did not test it for a particular clinician or location.
Our symptom-priority guide is relevant before that visit because a chronology can be more informative than a long checklist. A reader might identify the first concern they want addressed and another they do not want overlooked. The clinician still decides what can be assessed remotely and what requires a different kind of evaluation.
Separate the physician price from nutrition support
The pricing page describes different appointment roles. Its physician self-pay schedule lists $250 initially and $199 for follow-up. Dietitian appointments are $199 initially and $119 for follow-up, with longer initial dietitian sessions. Those dietitian prices should not be substituted for the cost of seeing the prescribing clinician.
The Stella review provides a comparison with another visit-based service that adds digital support. In both cases, it is useful to ask who an appointment is with and what that professional can address. A lower fee or a longer session with a different professional does not establish an equivalent clinical encounter or include the cost of medicines.
An insurance estimate is not the final claim
Gennev’s insurance explanation says its team estimates the copay, coinsurance or deductible after booking and receiving insurance information. A remaining balance may be billed after the claim is processed. Coverage also determines how many visits are included; being in network does not automatically mean an unlimited series of consultations.
This affects preparation in a practical way. Questions about the appointment’s purpose and expected follow-up can sit alongside questions about the estimate, without treating cost as a substitute for clinical judgment. The MyMenopauseRx assessment discusses a similar distinction between a published service and personal insurer liability. Neither review verifies benefits for an individual policy or guarantees reimbursement.
Give vaginal concerns their own place on the agenda
Gennev’s care record describes treatment of a range of menopause concerns and conditional prescriptions sent to the patient’s pharmacy. That does not mean the most noticeable hot flash will necessarily be the most important issue in someone’s visit. Vaginal discomfort may need an explicit mention rather than being left for the closing minute.
Our vaginal-symptom conversation guide supports describing the concern without self-diagnosing it. FDA menopause information distinguishes symptom treatment from prevention claims. The appropriate question is what assessment and options fit the concern described, not whether every menopause symptom should receive the same systemic treatment or whether a prescription is inevitable.
A dietitian referral does not replace the medical discussion
The pricing FAQ says a physician may refer someone to a Gennev registered dietitian nutritionist when clinically indicated. It describes dietary and lifestyle care with its own appointment charges and a schedule worked out with that professional. That is an additional care relationship, not evidence that everyone needs the same package.
A reader can ask what the referral is intended to address, what information is shared and which questions remain with the physician. This matters when concerns cross categories, such as sleep and changes in eating patterns. We have not evaluated Gennev’s referral coordination or outcomes. The public description supports asking about responsibilities; it does not prove that a referral will solve the original concern.
Earlier records can prevent an incomplete history
The service page asks for medical history and provides a place to view notes from the care team. For someone returning to hormone discussions after a long gap, the dates of earlier treatment and the reason it ended may be more useful than recalling that a prescription once worked or failed.
Our later-start guide focuses on that history without assigning eligibility from age alone. The bleeding-history guide addresses another detail that deserves clear communication. These preparation topics do not imply Gennev can investigate every concern through video. They help frame what the clinician may need to assess or refer elsewhere before an answer is possible.
Leave knowing what the next contact is for
Gennev says follow-up visits are often booked after hormone therapy or other medicines are prescribed. Its pricing information establishes a separate follow-up charge, but it does not provide a universal appointment schedule for every patient. A prescription transmitted on the same day is also not evidence that the pharmacy dispensed it or that all questions were resolved.
Useful closing questions concern the purpose of the next visit, how a new concern is communicated and who handles an issue between appointments. A payment receipt cannot supply those answers. Gennev’s public model is a structured video-care option; this review assesses that structure, not the quality of an unobserved conversation or a personal likelihood of improvement.
Read alongside the article
Sources & notes.
These sources provide provider descriptions or medical context. They do not replace an individual clinical assessment.
- Gennev: virtual menopause care ↗Provider service page; national access, visit timing and outcomes are company statements, not tested · Checked 2026-09-28
- Gennev: insurance and pricing ↗Provider visit-price and insurance-process record; pharmacy and individual claims are separate · Checked 2026-09-28
- FDA: Menopause ↗Current federal patient guidance; individualized benefits/risks and prevention limits, no class-wide labeling-change inference · Checked 2026-09-28